Message from ACMT Leadership

This Annual Report highlights the many accomplishments of another fruitful year and recognizes the impact of our brilliant ACMT membership. This dedication from staff, board of directors, and members have allowed ACMT and medical toxicologists to flourish. Through these professional achievements, every year ACMT comes closer to achieving our vision that “every patient and population benefits from the expertise of medical toxicologists.” We truly enjoy celebrating these successes.

2023 saw several new research funding opportunities that provided continued growth for our academic initiatives. ACMT has methodically continued expansion in grant awards while also becoming actively involved with the growing need for addiction toxicology. In this regard, we have secured grant support from FDA,CDC, and NIDA, among others. New funded programs in 2023 included  the Patient-Centered Outcomes Research Institute Program (PCORI), the Drug Overdose Toxico-Surveillance Program (DOTS), and the Real-World Examination of Naloxone for Drug Overdose Reversal Program (RENDOR).

Complementing this internal growth is the external surge to train in our fellowships. With this combination, we are poised to advance our specialty as a valued and recognized contributor to improve health care within the country and across the globe. We, therefore, have provided more opportunities for trainees and young investigators with NIDA funding to support the successful ANTIDOTE Institute, as well as  the Clinical Trials Network Dissemination Initiative Mentor-Facilitated Training Award.

Moreover, trainees have access to many ACMT and MTF programs to support their training. We are proud to offer a Medical Toxicology in Industry Rotation for fellows, a wide array of travel awards for students and residents, and several available grants to advance research for young investigators. We encourage you to review our websites and explore all our many offerings.

We are encouraged by your continued efforts, which collectively make our specialty valued, and a recognized contributor to health care. Our future is healthy and ready for the challenges that await. Together, ACMT will continue our unwavering commitment to steady growth and positive impact to our members and patients. We eagerly anticipate the future of Medical Toxicology and are committed to support the success of our members.

Anthony Pizon, MD, FACMT
ACMT Board President

Paul Wax, MD, FACMT
ACMT Executive Director